NCT04067336 2025-11-10First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaKura Oncology, Inc.Phase 1/2 Recruiting263 enrolled 1 FDA
NCT04537715 2025-02-19Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsIpsenPhase 1 Completed42 enrolled 39 charts